Coromandel International Limited: Navigating Q3 FY26 with Resilience and Strategic Growth
Coromandel International Limited, a prominent player in the Indian agricultural sector and part of the Murugappa Group, delivered a resilient performance in Q3 FY26 (October-December 2025), amidst a challenging macroeconomic and agricultural landscape. The company reported a consolidated revenue from operations of INR 8,779.45 crore, marking a significant 27% year-on-year growth. This robust top-line expansion was complemented by an EBITDA of INR 805 crore, a 12% increase from the previous year, and a Profit After Tax (PAT) of INR 488 crore. Despite facing headwinds from rising raw material costs and unseasonal weather, Coromandel demonstrated strong operational efficiency and strategic agility, reinforcing its market position.
The quarter saw India's GDP growth estimated at a healthy 7.4%, driven by services and manufacturing, with the RBI's repo rate reduction supporting domestic liquidity. However, the agricultural sector experienced some disruptions due to late withdrawal of the Southwest monsoon, impacting agri-input consumption in certain regions. Despite this, the Northeast monsoon was normal, and Rabi sowings showed a 3% year-on-year increase, indicating underlying agricultural resilience. Coromandel's performance reflects its ability to leverage internal strengths and strategic initiatives to mitigate external pressures.
Segmental Performance: A Closer Look
Coromandel's business is primarily divided into two key segments: Nutrient and other allied businesses, and Crop Protection. Both segments contributed to the company's overall growth, albeit with varying dynamics.
Nutrient and other allied business: This segment, the largest contributor, recorded revenue of INR 7,761.77 crore in Q3 FY26. Despite a 7% decline in overall industry fertilizer consumption due to unseasonal rains, Coromandel achieved its highest-ever quarterly fertilizer production of 9.9 lakh tons, an 18% increase year-on-year. The company's plants operated at 100% capacity utilization, showcasing strong operational efficiency. Coromandel has solidified its position as one of the largest phosphatic players in the country, with its share of unique grades improving from 33% to 36%. The company also took proactive price corrections (3-4%) to offset rising input costs and currency depreciation.
Crop Protection: The Crop Protection and Bio business delivered a strong standalone performance, with revenue growing by 24% to INR 785.11 crore and EBIT surging by 74% to INR 158 crore, pushing margins from 14% to 20%. This growth was fueled by favorable demand for key molecules in both export and domestic markets. Export growth was particularly strong, driven by volume uptick and higher net realizable value (NRV) of major technicals. The company expanded its channel presence, adding 1,000 new dealers during the year. The Nano DAP product continued its strong growth trajectory, becoming a market leader in its segment.
Strategic Initiatives and Future Outlook
Coromandel is actively pursuing several strategic initiatives to drive future growth and enhance operational resilience. The backward integration project at Kakinada for sulfuric acid and phosphoric acid is progressing well and is slated for commissioning this quarter. This project is expected to generate approximately INR 400 crore in annual EBITDA benefits, significantly improving cost control and supply security. Additionally, the granulation train expansion is on track for commissioning in Q3 FY27, further boosting manufacturing capacity.
The company's mining project in Senegal has stabilized operations and is on track to achieve an annual volume of 3.5 lakh tons of rock production this year, making it the largest exporter of rock phosphate from Senegal. This captive source meets 20-25% of Coromandel's rock requirements, providing a crucial strategic advantage. Furthermore, Coromandel is expanding its Mancozeb capacity by an additional 30% to meet growing demand in Latin American markets. The company has also commenced activity for a MAP water-soluble fertilizer plant project at Vizag, diversifying its Specialty Nutrient portfolio.
In the Crop Protection segment, Coromandel is focusing on new product development, including microbial platforms and partnerships for biological APIs. The company aims to increase its domestic formulation business by 20-25% year-on-year. The acquisition of NACL Industries Limited is also progressing, with efforts underway to realize synergies in R&D, manufacturing, marketing, and registration. NACL's credit rating was upgraded to CRISIL AA stable, and its EBITDA margins are expected to improve to 9-10%.
Management Commentary and Investor Confidence
Management acknowledged the challenges posed by external factors like unseasonal rains and raw material price volatility but highlighted the company's proactive measures, such as price corrections and moderated sales, to align with market realities. They expressed confidence in sustaining or improving CPC standalone margins in the 20% range. The company's focus on operational excellence, cost discipline, and long-term value creation remains steadfast.
The timely collection of subsidies, despite an increase in outstanding amounts, further supports the company's liquidity. Coromandel's strategic investments, product diversification, and market expansion initiatives position it well for sustained growth. The management's transparent communication and proactive approach to market dynamics instill confidence in its ability to navigate future challenges and capitalize on emerging opportunities.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
